Latest Health News

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

Oliver’s Real Food Limited reported a striking turnaround in its September 2025 quarter, with EBIT soaring 192% and operating cash flow swinging positive despite a dip in overall revenue.

TrivarX Limited has announced the acquisition of Stabl-Im, a novel stable isotope MRI technology for early brain tumor detection, backed by a $4.2 million capital raise including investment from biotech leader Dr Daniel Tillett.

Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.

Bannerman Energy reports solid progress at its Etango Uranium Project, securing initial offtake agreements and maintaining robust financial health as it targets a Final Investment Decision within the next year.

Bannerman Energy Ltd reported a robust cash position of AUD 111.76 million at the end of September 2025, underpinning an estimated 13.5 quarters of operational funding despite ongoing exploration expenditures.

Southern Cross Media Group reports a robust Q1 FY26 with audio revenues rising 4.7% and EBITDA more than doubling, while preparing for a pivotal merger review.

AIC Mines reports robust production and cash flow from Eloise, advances Jericho development with promising drilling, and kicks off a major processing plant expansion.

Enero Group reports improved profitability in FY25 despite revenue decline, driven by divestment and AI innovation, with FY26 Q1 EBITDA up 13%.

EVE Health Group Limited has launched a $1.1 million capital raising via a placement to fund the commercial rollout of its two pharmaceutical products, Dyspro and Libbo. The offer includes shares and options, with some subject to shareholder approval.

Audeara Limited has landed its maiden purchase order for hearing aid technology in China, marking a pivotal step in its global expansion with production and launch planned for the final quarter of 2025.

Beamtree Holdings has reported a 9% increase in recurring revenue for Q1 FY26, driven by strong contract wins and international expansion, including a key UK NHS partnership and a new autonomous coding rollout.